| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.02 |